Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Vaccine
1100%
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Angel PharmaceuticalsChina - Zhejiang
1 program1
Nonavalent HPV vaccinePhase 4Vaccine1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Angel PharmaceuticalsNonavalent HPV vaccine
Clinical Trials (1)
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
Start: Sep 2022Est. completion: Dec 2026
Phase 4Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
1 companies competing in this space